ALIN
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

ALIN Trademark

Serial Number: 97005028 • Registration: 7498122

ALIN is a trademark filed by Productos Farmaceuticos S.A. de C.V. on August 31, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Productos Farmaceuticos S.A. de C.V. (28 trademarks)

Colonia Granada
Mexico City , MX

Entity Type: 03

Trademark Details

Filing Date

August 31, 2021

Registration Date

September 10, 2024

Published for Opposition

June 25, 2024

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 10, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 10, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 25, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jun 25, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 5, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 17, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 30, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 30, 2024 CRFA
ASSIGNED TO LIE
Apr 30, 2024 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Dec 11, 2023 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Nov 29, 2023 GNS2
INQUIRY TO SUSPENSION E-MAILED
Nov 29, 2023 GNSI
SUSPENSION INQUIRY WRITTEN
Nov 29, 2023 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 1, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 1, 2023 GNSL
SUSPENSION LETTER WRITTEN
Jun 1, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
May 31, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 30, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 30, 2023 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Nov 30, 2022 GPRN
PRIORITY ACTION E-MAILED
Nov 30, 2022 GPRA
PRIORITY ACTION WRITTEN
Nov 30, 2022 CPRA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 4, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jun 4, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jun 4, 2022 CNRT
ASSIGNED TO EXAMINER
Jun 4, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 14, 2021 NWOS
NEW APPLICATION ENTERED
Sep 3, 2021 NWAP